Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fraud
Biotech
Novo to sue kidney disease drug maker for alleged fraud
Novo plans to seek $830 million in damages from Singapore-based KBP Biosciences and KBP’s founder and executive chairman, Zhenhua Huang, Ph.D.
Darren Incorvaia
Feb 18, 2025 3:00pm
Jury convicts 2 former biopharma leaders of fraud
Dec 11, 2024 10:26am
Thousands of children tested for lead with faulty devices
Jun 10, 2024 3:10pm
SEC joins DOJ in charging Stimwave ex-CEO with fraud
Dec 21, 2023 12:17pm
Pain clinic settles Medicare, Medicaid fraud claims for $11.4M
Jul 28, 2023 12:48pm
Elizabeth Holmes reports to prison for 11-year sentence
May 30, 2023 1:38pm
